504 related articles for article (PubMed ID: 30856406)
1. Lenvatinib-zinc phthalocyanine conjugates as potential agents for enhancing synergistic therapy of multidrug-resistant cancer by glutathione depletion.
Wei G; Huang L; Jiang Y; Shen Y; Huang Z; Huang Y; Sun X; Zhao C
Eur J Med Chem; 2019 May; 169():53-64. PubMed ID: 30856406
[TBL] [Abstract][Full Text] [Related]
2. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy.
Huang L; Wei G; Sun X; Jiang Y; Huang Z; Huang Y; Shen Y; Xu X; Liao Y; Zhao C
Eur J Med Chem; 2018 May; 151():294-303. PubMed ID: 29627724
[TBL] [Abstract][Full Text] [Related]
3. Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity.
Xu P; Chen J; Chen Z; Zhou S; Hu P; Chen X; Huang M
PLoS One; 2012; 7(5):e37051. PubMed ID: 22693566
[TBL] [Abstract][Full Text] [Related]
4. Enhanced photodynamic efficacy of zinc phthalocyanine by conjugating to heptalysine.
Li L; Luo Z; Chen Z; Chen J; Zhou S; Xu P; Hu P; Wang J; Chen N; Huang J; Huang M
Bioconjug Chem; 2012 Nov; 23(11):2168-72. PubMed ID: 23057652
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy.
Hu M; Brasseur N; Yildiz SZ; van Lier JE; Leznoff CC
J Med Chem; 1998 May; 41(11):1789-802. PubMed ID: 9599230
[TBL] [Abstract][Full Text] [Related]
6. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy.
Gao D; Lo PC
J Control Release; 2018 Jul; 282():46-61. PubMed ID: 29673646
[TBL] [Abstract][Full Text] [Related]
7. Multiple Functions Integrated inside a Single Molecule for Amplification of Photodynamic Therapy Activity.
Shi X; Zhan Q; Li Y; Zhou L; Wei S
Mol Pharm; 2020 Jan; 17(1):190-201. PubMed ID: 31804837
[TBL] [Abstract][Full Text] [Related]
8. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
[TBL] [Abstract][Full Text] [Related]
9. Novel zinc phthalocyanine as a promising photosensitizer for photodynamic treatment of esophageal cancer.
Kuzyniak W; Schmidt J; Glac W; Berkholz J; Steinemann G; Hoffmann B; Ermilov EA; Gürek AG; Ahsen V; Nitzsche B; Höpfner M
Int J Oncol; 2017 Mar; 50(3):953-963. PubMed ID: 28098886
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
[TBL] [Abstract][Full Text] [Related]
11. Pre-drug Self-assembled Nanoparticles: Recovering activity and overcoming glutathione-associated cell antioxidant resistance against photodynamic therapy.
Xu K; Yao H; Hu J; Zhou J; Zhou L; Wei S
Free Radic Biol Med; 2018 Aug; 124():431-446. PubMed ID: 29981371
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric ZnPc-rhodamine B conjugates for mitochondrial targeted photodynamic therapy.
Muli DK; Rajaputra P; You Y; McGrath DV
Bioorg Med Chem Lett; 2014 Sep; 24(18):4496-4500. PubMed ID: 25150377
[TBL] [Abstract][Full Text] [Related]
13. Self-Assembled Matrine-PROTAC Encapsulating Zinc(II) Phthalocyanine with GSH-Depletion-Enhanced ROS Generation for Cancer Therapy.
Lai S; Wang B; Sun K; Li F; Liu Q; Yu XA; Jiang L; Wang L
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675664
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of hepatocellular carcinoma using tetra-triethyleneoxysulfonyl zinc phthalocyanine as photosensitizer.
Ogbodu RO; Nitzsche B; Ma A; Atilla D; Gürek AG; Höpfner M
J Photochem Photobiol B; 2020 Jul; 208():111915. PubMed ID: 32480203
[TBL] [Abstract][Full Text] [Related]
15. A ROS responsive nanomedicine with enhanced photodynamic therapy via dual mechanisms: GSH depletion and biosynthesis inhibition.
Hu J; Wang T; Zhou L; Wei S
J Photochem Photobiol B; 2020 Aug; 209():111955. PubMed ID: 32653858
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Activity Study and Density Functional/Time-Dependent Density Functional Theory (DFT/TD-DFT) Calculations of 2(3),9(10),16(17),23(24)-Tetrakis-(6-Methylpyridin-2-Yloxy)Phthalocyaninato Zn(II).
Karagöz ID; Yilmaz Y; Sanusi K
J Fluoresc; 2020 Sep; 30(5):1151-1160. PubMed ID: 32648171
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib-Conjugated Zinc Phthalocyanine Based Nanocapsule for Trimodal Therapy in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.
Yu XN; Deng Y; Zhang GC; Liu J; Liu TT; Dong L; Zhu CF; Shen XZ; Li YH; Zhu JM
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17193-17206. PubMed ID: 32207914
[TBL] [Abstract][Full Text] [Related]
18. Peptide 18-4/chlorin e6-conjugated polyhedral oligomeric silsesquioxane nanoparticles for targeted photodynamic therapy of breast cancer.
Kim YJ; Lee HI; Kim JK; Kim CH; Kim YJ
Colloids Surf B Biointerfaces; 2020 May; 189():110829. PubMed ID: 32036332
[TBL] [Abstract][Full Text] [Related]
19. Anti-Psoriasis Effects and Mechanisms of Α-(8-Quinolinoxy) Zinc Phthalocyanine-Mediated Photodynamic Therapy.
Liu HQ; Wang YM; Li WF; Li C; Jiang ZH; Bao J; Wei JF; Jin HT; Wang AP
Cell Physiol Biochem; 2017; 44(1):200-214. PubMed ID: 29131032
[TBL] [Abstract][Full Text] [Related]
20. C-Phycocyanin as a tumour-associated macrophage-targeted photosensitiser and a vehicle of phthalocyanine for enhanced photodynamic therapy.
Wan DH; Zheng BY; Ke MR; Duan JY; Zheng YQ; Yeh CK; Huang JD
Chem Commun (Camb); 2017 Apr; 53(29):4112-4115. PubMed ID: 28349131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
